Olivier Visa was named President and Chief Executive Officer in July 2020. In this role, Olivier leads the company toward accelerated growth, enhanced employee development, patient-centric innovation, and deep customer engagement.
Olivier joined the company in 2017 as the OEM Franchise leader with over 28 years of life sciences leadership experience. He is highly regarded for driving focus on patient outcomes and team collaboration to lead dynamic business transformation and build sustainable value. Before Evergen, Olivier served as Vice President of the Global Compounding business unit of Baxter Healthcare, where he led, with the support of the country leaders, the acceleration of profitable growth with a relentless focus on patient safety. Before this role, he had multiple commercial leadership responsibilities worldwide, including Baxter Pharmaceuticals and Technology and its global contract manufacturing business.
Olivier earned a doctorate degree in pharmacy from the University of Aix Marseille II and a Master of Business Administration from the Kellogg School of Management at Northwestern University.